Peripheral Blood T-lymphocyte Phenotypes in Mother-Child Pairs Stratified by the Maternal HPV Status: Persistent HPV16 vs. HPV-Negative: A Case-Control Study

Only few studies exist on the phenotype distribution of peripheral blood lymphocytes concerning persistent oral HPV infection. T-lymphocyte subsets were phenotyped in women who had persistent genital or oral HPV16 infection, using HPV-negative women as a reference group. A subset of 42 mothers and their children (n = 28), were stratified into two groups according to the mothers’ HPV status. PBMCs from previously cryopreserved venous samples were immunophenotyped by flow cytometry. Proportions of the CD4+ or CD8+ lymphocytes by their immunophenotype subsets were compared between HPV-positive and -negative mothers and their children. The mean rank distribution of CD8+ memory cells was significantly higher among mothers with persistent genital HPV16 infection. The median levels of both the antigen-presenting CD4+ cells and activated CD8+ cells were significantly lower in mothers with persistent oral HPV16 infection. When oral and genital HPV16-persistors were analyzed as a group, a marker of terminal effector cells was significantly increased as compared to HPV-negative women. Significantly higher levels of activated CD4+, CD8+ and circulating CD8+ memory cells were found among children whose mothers had persistent oral HPV16 infection. Persistent HPV16 infections are associated with changes in peripheral blood T-lymphocyte subsets. The mother’s persistent oral HPV16 infection possibly results in immune alterations in her offspring.

[1]  M. Pawlita,et al.  Maternal HPV-antibodies and seroconversion to HPV in children during the first 3 years of life , 2022, Scientific Reports.

[2]  M. Neagu,et al.  Assessment of Immune Cell Populations in Tumor Tissue and Peripheral Blood Samples from Head and Neck Squamous Cell Carcinoma Patients , 2021, Analytical cellular pathology.

[3]  M. G. Bonecini-Almeida,et al.  A prognostic value of CD45RA+, CD45RO+, CCL20+ and CCR6+ expressing cells as ‘immunoscore’ to predict cervical cancer induced by HPV , 2021, Scientific Reports.

[4]  S. Grénman,et al.  Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland , 2021, Emerging infectious diseases.

[5]  S. H. van der Burg,et al.  Interferon‐γ and IL‐5 associated cell‐mediated immune responses to HPV16 E2 and E6 distinguish between persistent oral HPV16 infections and noninfected mucosa , 2021, Clinical and experimental dental research.

[6]  M. Stanley,et al.  Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis , 2020, British Journal of Cancer.

[7]  M. Zvâncă,et al.  Non-sexual HPV transmission and role of vaccination for a better future (Review). , 2020, Experimental and therapeutic medicine.

[8]  M. Moneer,et al.  Frequency of CD4+ regulatory T cells, CD8+ T cells, and human papilloma virus infection in Egyptian Women with breast cancer , 2020, International journal of immunopathology and pharmacology.

[9]  Renu Yadav,et al.  Immunology of HPV-mediated cervical cancer: current understanding , 2020, International reviews of immunology.

[10]  J. Cuzick,et al.  Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[11]  E. Wherry,et al.  CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. , 2019, Annual review of immunology.

[12]  Dong Kyu Lee,et al.  What is the proper way to apply the multiple comparison test? , 2018, Korean journal of anesthesiology.

[13]  R. Barnabas,et al.  HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer , 2018, AIDS.

[14]  P. Stern,et al.  Opportunities and challenges for human papillomavirus vaccination in cancer , 2018, Nature Reviews Cancer.

[15]  A. Kamphorst,et al.  CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. , 2018, Annual review of medicine.

[16]  A. Stensballe,et al.  Induction of a Regulatory Phenotype in CD3+ CD4+ HLA-DR+ T Cells after Allogeneic Mixed Lymphocyte Culture; Indications of Both Contact-Dependent and -Independent Activation , 2017, International journal of molecular sciences.

[17]  A. Nyitray,et al.  Penises not required: a systematic review of the potential for human papillomavirus horizontal transmission that is non-sexual or does not include penile penetration. , 2016, Sexual health.

[18]  L. Montaner,et al.  High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women , 2016, Oncoimmunology.

[19]  Sing Sing Way,et al.  Regulatory T cell memory , 2015, Nature Reviews Immunology.

[20]  M. Grimm,et al.  Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue , 2016, Tumor Biology.

[21]  S. H. van der Burg,et al.  Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative , 2015, Journal of Translational Medicine.

[22]  S. H. van der Burg,et al.  Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years , 2015, Journal of Translational Medicine.

[23]  S. H. van der Burg,et al.  Human papillomavirus 16 E2-, E6- and E7-specific T-cell responses in children and their mothers who developed incident cervical intraepithelial neoplasia during a 14-year follow-up of the Finnish Family HPV cohort , 2014, Journal of Translational Medicine.

[24]  M. Kee,et al.  Distribution of maternal and infant human papillomavirus: risk factors associated with vertical transmission. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[25]  S. Weyers,et al.  Transmission of carcinogenic human papillomavirus types from mother to child: a meta-analysis of published studies , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[26]  Yali Hu,et al.  Survey of human papillomavirus types and their vertical transmission in pregnant women , 2013, BMC Infectious Diseases.

[27]  M. Shipkova,et al.  Surface markers of lymphocyte activation and markers of cell proliferation. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[28]  M. Pawlita,et al.  Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes. , 2012, The Journal of pediatrics.

[29]  M. Pawlita,et al.  Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa. , 2011, The Journal of general virology.

[30]  Xin Chen,et al.  The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4+ FoxP3+ regulatory T cells , 2011, Immunology.

[31]  M. Schiffman,et al.  Alterations of T‐cell surface markers in older women with persistent human papillomavirus infection , 2011, International journal of cancer.

[32]  S. H. van der Burg,et al.  Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine , 2008, Clinical Cancer Research.

[33]  E. Schuuring,et al.  Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia , 2007, Clinical and experimental immunology.

[34]  Clare Baecher-Allan,et al.  MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells1 , 2006, The Journal of Immunology.

[35]  Peter J. F. Snijders,et al.  Bead-Based Multiplex Genotyping of Human Papillomaviruses , 2006, Journal of Clinical Microbiology.

[36]  R. Lechler,et al.  Acquisition of HLA‐DR and Costimulatory Molecules by T Cells from Allogeneic Antigen Presenting Cells , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[37]  N. Kiviat,et al.  Development and duration of human papillomavirus lesions, after initial infection. , 2005, The Journal of infectious diseases.

[38]  G. Tortolero-Luna,et al.  Human papillomavirus infection: biology, epidemiology, and prevention , 2005, International Journal of Gynecologic Cancer.

[39]  S. Grénman,et al.  Transmission of High-Risk Human Papillomavirus (HPV) between Parents and Infant: a Prospective Study of HPV in Families in Finland , 2005, Journal of Clinical Microbiology.

[40]  J. M. van der Hulst,et al.  Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6 , 2004, Cancer Research.

[41]  P. J. van den Elsen,et al.  Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. , 2004, Human immunology.

[42]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[43]  R. Lechler,et al.  Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? , 2003, Blood.

[44]  J. M. van der Hulst,et al.  Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter. , 2003, Cancer research.

[45]  R. Seufert,et al.  CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7 , 2002, Zentralblatt fur Gynakologie.

[46]  E. Wang,et al.  Analysis of CD4+ T-Cell Responses to Human Papillomavirus (HPV) Type 11 L1 in Healthy Adults Reveals a High Degree of Responsiveness and Cross-Reactivity with Other HPV Types , 2002, Journal of Virology.

[47]  A. Rickinson,et al.  Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection , 2002, The Journal of experimental medicine.

[48]  P. Coursaget,et al.  Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome. , 1999, The Journal of general virology.

[49]  C. Meijer,et al.  Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. , 1998, Cancer research.

[50]  T. Wyss-Coray,et al.  T cells as antigen-presenting cells. , 1994, Immunology today.